new models of care

Views & Analysis

These are challenging times in the NHS, with reforms and budget restrictions putting the health service under huge strain.

News

Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.